Tenderwize
Zurück zur Suche

Open House Discount Agreement for Sultamicillin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sultamicillin, ATC J01CR04

20/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

20 / 100

Komplexität

15 / 100

Risikofaktoren

No contract value or volume estimates provided. The opportunity may be small if Sultamicillin is a niche product.

The buyer reserves the right to replace Open House contracts with exclusive discount agreements from EU tenders at any...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive discount agreements for Sultamicillin (ATC J01CR04) under German social code SGB V §§ 130a Abs. 8/130c Abs. 1.
  • Pharmaceutical companies can enroll at any time during the 24-month window (01.06.2025 – 31.05.2027), with contracts starting on the first of each month.
Vollständige Zusammenfassung anzeigen

Non-exclusive discount agreement (Open House) for pharmaceutical products with active ingredient Sultamicillin (ATC J01CR04) by AOK Rheinland-Pfalz/Saarland. The contract period runs from 01.06.2025 to 31.05.2027, with continuous enrollment possible each month. This is not a public procurement contract subject to EU directives but a voluntary transparency publication. No estimated value or award criteria are specified. Submission is paper-only. The place of performance is Eisenberg, Germany. The tender is EU-funded according to structured data, but XML notice indicates no EU funds (inconsistency noted).

Risiken

No contract value or volume estimates provided. The opportunity may be small if Sultamicillin is a niche product.

The buyer reserves the right to replace Open House contracts with exclusive discount agreements from EU tenders at any...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Only authorized and marketable drugs in Germany may be supplied.
  • For drugs not yet listed in Lauer-Taxe at time of application, proof of marketability via AMIce database extract or equivalent evidence is required.

Administrative

  • Submission must be in paper form (electronic submission not allowed).

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria specified; the Open House model implies all eligible participants are accepted.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreement for Sultamicillin

Non-exclusive discount agreement for Sultamicillin. All interested pharmaceutical companies can join under uniform conditions. Maximum contract duration 24 months, earliest start 01.06.2025. Contract ends automatically if exclusive discount agreements are concluded via EU tender. Applications must be submitted in paper form by the end of the month prior to the desired start month.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria specified; the Open House model implies all eligible participants are accepted.

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
235368-2025

Dokumente (1)

Ähnliche Ausschreibungen